Highlights from SABCS featuring new multimodal AI models developed by ECOG-ACRIN and Caris to advance recurrence risk assessment and personalized care in early-stage breast cancer
This companion study aims to build a biobank of primary and relapse tumor tissue samples to identify factors driving breast cancer recurrence despite treatment